| MTOR |
AKT(PKB)-Bad signaling ( EPO signaling pathway(JAK2 STAT1 STAT3 STAT5) ) |
inoh |
173 |
2371 |
| MTOR |
AKT(PKB)-Bad signaling ( IL-7 signaling(JAK1 JAK3 STAT5) ) |
inoh |
173 |
2371 |
| MTOR |
AKT(PKB)-mTOR signaling ( Insulin receptor signaling (Mammal) ) |
inoh |
15 |
52 |
| MTOR |
AKT(PKB)-TOR signaling ( Insulin receptor signaling (D. melanogaster) ) |
inoh |
15 |
52 |
| MTOR |
AKT(PKB) activation signaling ( Insulin receptor signaling (Mammal) ) |
inoh |
13 |
57 |
| MTOR |
Alpha6Beta4Integrin |
netpath |
74 |
899 |
| MTOR |
CD28 dependent PI3K/Akt signaling |
reactome |
22 |
122 |
| MTOR |
CDC42 signaling events |
pid |
71 |
630 |
| MTOR |
Class I PI3K signaling events mediated by Akt |
pid |
35 |
293 |
| MTOR |
Constitutive Signaling by AKT1 E17K in Cancer |
reactome |
25 |
137 |
| MTOR |
CXCR3-mediated signaling events |
pid |
38 |
318 |
| MTOR |
CXCR4-mediated signaling events |
pid |
87 |
1183 |
| MTOR |
Drosophila Toll-like receptor signaling ( Drosophila Toll-like receptor signaling ) |
inoh |
236 |
3833 |
| MTOR |
EGFR-dependent Endothelin signaling events |
pid |
9 |
30 |
| MTOR |
EGFR1 |
netpath |
475 |
10010 |
| MTOR |
Energy dependent regulation of mTOR by LKB1-AMPK |
reactome |
28 |
281 |
| MTOR |
ErbB1 downstream signaling |
pid |
105 |
1597 |
| MTOR |
ErbB2/ErbB3 signaling events |
pid |
41 |
404 |
| MTOR |
FSH |
netpath |
44 |
301 |
| MTOR |
HSF1-dependent transactivation |
reactome |
34 |
190 |
| MTOR |
Hypoxia response via HIF activation |
panther |
16 |
37 |
| MTOR |
IFN-gamma pathway |
pid |
43 |
345 |
| MTOR |
IL12-mediated signaling events |
pid |
62 |
684 |
| MTOR |
IL2 |
netpath |
81 |
1364 |
| MTOR |
IL2 signaling events mediated by PI3K |
pid |
38 |
397 |
| MTOR |
IL4-mediated signaling events |
pid |
66 |
512 |
| MTOR |
Insulin receptor signaling ( Insulin receptor signaling (D. melanogaster) ) |
inoh |
55 |
525 |
| MTOR |
Insulin receptor signaling (Mammal) ( Insulin receptor signaling (Mammal) ) |
inoh |
58 |
648 |
| MTOR |
Interleukin signaling pathway |
panther |
86 |
1548 |
| MTOR |
KitReceptor |
netpath |
104 |
1591 |
| MTOR |
Leptin |
netpath |
98 |
1355 |
| MTOR |
Leucine Stimulation on Insulin Signaling |
smpdb |
15 |
49 |
| MTOR |
LKB1 signaling events |
pid |
43 |
314 |
| MTOR |
Macroautophagy |
reactome |
67 |
696 |
| MTOR |
mTOR signaling pathway |
pid |
66 |
641 |
| MTOR |
mTOR signalling |
reactome |
16 |
120 |
| MTOR |
mTORC1-mediated signalling |
reactome |
22 |
168 |
| MTOR |
PIP3 activates AKT signaling |
reactome |
81 |
2003 |
| MTOR |
Positive regulation of (Transcription of SOCS by STAT dimer) in JAK STAT pathway ( JAK-STAT pathway and regulation pathway Diagram ) |
inoh |
178 |
3507 |
| MTOR |
Prolactin |
netpath |
105 |
1733 |
| MTOR |
RANKL |
netpath |
84 |
1002 |
| MTOR |
Regulation of Telomerase |
pid |
70 |
708 |
| MTOR |
Regulation of TP53 Degradation |
reactome |
35 |
257 |
| MTOR |
Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
pid |
80 |
1068 |
| MTOR |
TGF_beta_Receptor |
netpath |
220 |
4100 |
| MTOR |
TNFalpha |
netpath |
274 |
5236 |
| MTOR |
TP53 Regulates Metabolic Genes |
reactome |
85 |
651 |
| MTOR |
TSH |
netpath |
82 |
750 |
| MTOR |
VEGF signaling pathway ( VEGF signaling pathway ) |
inoh |
183 |
2778 |
| MTOR |
VEGFR2 mediated vascular permeability |
reactome |
29 |
169 |
| MTOR |
ErbB signaling pathway |
kegg |
83 |
1425 |
| MTOR |
mTOR signaling pathway |
kegg |
50 |
342 |
| MTOR |
Insulin signaling pathway |
kegg |
134 |
1756 |
| MTOR |
Adipocytokine signaling pathway |
kegg |
65 |
539 |
| MTOR |
Type II diabetes mellitus |
kegg |
44 |
261 |
| MTOR |
Pathways in cancer |
kegg |
321 |
8293 |
| MTOR |
Glioma |
kegg |
65 |
998 |
| MTOR |
Prostate cancer |
kegg |
85 |
1261 |
| MTOR |
Acute myeloid leukemia |
kegg |
53 |
562 |
| MTOR |
Hs_BDNF-TrkB_Signaling_WP3676_89741 |
wikipathways |
14 |
36 |
| MTOR |
Hs_ErbB_Signaling_Pathway_WP673_91869 |
wikipathways |
37 |
312 |
| MTOR |
Hs_Factors_and_pathways_affecting_insulin-like_growth_factor_(IGF1)-Akt_signaling_WP3850_88165 |
wikipathways |
19 |
51 |
| MTOR |
Hs_Thyroid_Stimulating_Hormone_(TSH)_signaling_pathway_WP2032_89823 |
wikipathways |
28 |
79 |
| MTOR |
Hs_Leptin_signaling_pathway_WP2034_89856 |
wikipathways |
37 |
264 |
| MTOR |
Hs_Target_Of_Rapamycin_(TOR)_Signaling_WP1471_90258 |
wikipathways |
5 |
11 |
| MTOR |
Hs_Wnt_Signaling_Pathway_Netpath_WP363_78571 |
wikipathways |
28 |
133 |
| MTOR |
Hs_MECP2_and_Associated_Rett_Syndrome_WP3584_91190 |
wikipathways |
12 |
14 |
| MTOR |
Hs_Integrated_Breast_Cancer_Pathway_WP1984_82941 |
wikipathways |
122 |
1333 |
| MTOR |
Hs_VEGFA-VEGFR2_Signaling_Pathway_WP3888_90000 |
wikipathways |
153 |
1949 |
| MTOR |
Hs_Cardiac_Hypertrophic_Response_WP2795_85087 |
wikipathways |
23 |
82 |
| MTOR |
Hs_Sterol_Regulatory_Element-Binding_Proteins_(SREBP)_signalling_WP1982_90425 |
wikipathways |
15 |
31 |
| MTOR |
Hs_4-hydroxytamoxifen,_Dexamethasone,_and_Retinoic_Acids_Regulation_of_p27_Expression_WP3879_90124 |
wikipathways |
6 |
6 |
| MTOR |
Hs_Type_II_diabetes_mellitus_WP1584_81779 |
wikipathways |
14 |
32 |
| MTOR |
Hs_Urea_cycle_and_metabolism_of_amino_groups_WP497_72142 |
wikipathways |
8 |
7 |
| MTOR |
Hs_TGF-beta_Signaling_Pathway_WP366_90028 |
wikipathways |
67 |
576 |
| MTOR |
Hs_Prolactin_Signaling_Pathway_WP2037_90015 |
wikipathways |
52 |
570 |
| MTOR |
Hs_Brain-Derived_Neurotrophic_Factor_(BDNF)_signaling_pathway_WP2380_89803 |
wikipathways |
80 |
623 |
| MTOR |
Hs_EGF-EGFR_Signaling_Pathway_WP437_79266 |
wikipathways |
107 |
1336 |
| MTOR |
Hs_Alpha_6_Beta_4_signaling_pathway_WP244_85199 |
wikipathways |
19 |
136 |
| MTOR |
Hs_RANKL-RANK_(Receptor_activator_of_NFKB_(ligand))_Signaling_Pathway_WP2018_90016 |
wikipathways |
26 |
125 |
| MTOR |
Hs_Follicle_Stimulating_Hormone_(FSH)_signaling_pathway_WP2035_86080 |
wikipathways |
20 |
71 |
| MTOR |
Hs_Insulin_signalling_in_adipocytes_(diabetic_condition)_WP3635_86059 |
wikipathways |
6 |
9 |
| MTOR |
Hs_Insulin_signalling_in_adipocytes_(normal_condition)_WP3634_86060 |
wikipathways |
6 |
9 |